The expression and function of Nedd4-2 (Neural precursor cell-expressed developmentally down-regulated protein 4-2) in glioblastoma
Year: 2017
Type: dissertation
Abstract: Glioblastoma (GBM), formerly known as glioblastoma multiforme, is a grade IV brain cancer, which is the most malignant form of cancer in the central nervous system.To date, there is no curative treatment for GBM and the median survival period of GBM patients is 14 months.Different approaches have been taken in the search for a more effective GBM therapy.Since about a decade ago, ubiquitin ligases have been reported to be potential therapeutic targets for human malignancies.Nedd4-2 (Neural precursor cell-expressed developmentally down-regulated protein 4-2) is a ubiquitin ligase that has been found to influence tumorigenesis.However, the involvement of Nedd4-2 in GBM is still unknown.Hence, this project aims to: (1) study the expression of Nedd4-2 in human GBM samples; (2) investigate the function and role of Nedd4-2 in GBM tumorigenesis; and (3) explore the molecular mechanisms of the relationship between Nedd4-2 and EGFR (epidermal growth factor receptor), one of the most mutated proteins in GBM.Studies of Nedd4-2 expression in human GBM tumour and peri-tumour tissues in the first result chapter reveal a higher Nedd4-2 expression in the tumour compared to the peri-tumour tissues.Nedd4-2 is also expressed in glioma stem cells isolated from GBM patients.To further explore the role of Nedd4-2 in GBM, Nedd4-2 expression was manipulated, after which several cell-based assays were used to investigate its effects.Chapter 3 in this thesis discloses that Nedd4-2 overexpression and underexpression do not significantly affect cell proliferation, migration and death in U87, LN18 and HEK293T cells.In addition, Nedd4-2 overexpression does not have a significant effect on the activation of the PI3K and MAPK signalling pathways.However, due to the characteristics of GBM as a highly heterogeneous tumour, the involvement of Nedd4-2 in GBM pathogenesis cannot be discounted. IIThe most prominent finding of this study is the discovery of a positive correlation between Nedd4-2 and EGFR expression in GBM clinical samples.Biochemical assays, including protein-protein interaction and ubiquitination assays, were carried out to further dissect the molecular mechanisms underlying this observation.Both Nedd4-2 and a mutant form of Nedd4-2 interact with EGFR in vitro, with the mutant showing a stronger binding affinity.Surprisingly, further investigation discovered that the Nedd4-2 mutant increases the expression and ubiquitination levels of EGFR in the cells.Wild type Nedd4-2, but not the mutant, is found to be self-ubiquitinated and degraded.Interestingly, in the presence of proteasome inhibitor to block Nedd4-2 selfdegradation, Nedd4-2 accumulation leads to increases in EGFR expression and ubiquitination levels in the cells.In summary, this thesis provides novel evidence that Nedd4-2 is highly expressed in human GBM tumour compared to peri-tumour tissues.Both Nedd4-2 overexpression and underexpression do not significantly affect cell proliferation, cell migration, and cell death, as well as PI3K and MAPK signalling pathway activation in the cell lines tested.This work also reports that Nedd4-2 interacts with EGFR where the accumulation of Nedd4-2 leads to increased levels of EGFR expression and ubiquitination in the cells.Therefore, it is proposed that the binding of Nedd4-2 to EGFR stabilises EGFR in the cells, thereby preventing the degradation of EGFR.Increased in EGFR cellular level subsequently results in GBM tumorigenesis.
Author: Yuh-Lit Chow
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2768413068
